波形蛋白(VIM)真核蛋白
Eukaryotic Vimentin (VIM)
- 編號(hào)EPB040Hu61
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源真核表達(dá)
- 宿主293F cell
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞膜, 細(xì)胞核, 細(xì)胞質(zhì)
- 預(yù)測分子量14.6kDa
- 實(shí)際分子量15kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ser144~Glu251 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)4.2
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1440¥ 3600¥ 7200¥ 21600¥ 54000
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB040Hu02 | 波形蛋白(VIM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB040Hu01 | 波形蛋白(VIM)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB040Hu01 | 波形蛋白(VIM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB040Hu61 | 波形蛋白(VIM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB040Hu62 | 波形蛋白(VIM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB040Hu02 | 波形蛋白(VIM)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB040Hu01 | 波形蛋白(VIM)多克隆抗體 | WB; IHC; ICC/IF |
| LAB040Hu71 | 波形蛋白(VIM)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB040Hu24 | 波形蛋白(VIM)單克隆抗體 | WB; IHC |
| MAB040Hu25 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; IF |
| MAB040Hu21 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB040Hu23 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB040Hu27 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB040Hu22 | 波形蛋白(VIM)單克隆抗體 | WB; IHC; ICC/IF |
| FAB040Hu02 | 抗波形蛋白(VIM)單克隆抗體 | Flow cytometry. |
| FAB040Hu06 | 抗波形蛋白(VIM)單克隆抗體 | Flow cytometry. |
| FAB040Hu04 | 抗波形蛋白(VIM)單克隆抗體 | Flow cytometry. |
| FAB040Hu08 | 抗波形蛋白(VIM)單克隆抗體 | Flow cytometry. |
| SEB040Hu | 波形蛋白(VIM)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB040Hu | 波形蛋白(VIM)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB040Hu01 | 波形蛋白(VIM)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Cancer?Epidemiology,?Biomarkers?& Prevention | Aberrant Vimentin Methylation Is Characteristic of Breast Cancer[pubmed:22315367] |
| Scientific Reports | Glyoxalase?1-knockdown?in?human?aortic?endothelial?cells - effect on the?proteome?andendothelial?function?estimates.[pubmed:27898103] |
| Journal of?Proteomics | HtrA3 is a cellular partner of cytoskeleton proteins and TCP1α chaperonin[Pubmed:29477555] |
| Journal of Biological Chemistry | Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy[Pubmed: 31511328] |
| American Journal of Transplantation | Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts[Pubmed: 31729155] |
| Lung | Is Vimentin the Cause or Effect of Obstructive Sleep Apnea Development?[Pubmed: 32088750] |
| Cell Biol Toxicol | ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer[33566221] |
| CELL BIOLOGY AND TOXICOLOGY | Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence[33758996] |
| Comparison of Vimentin Levels Between Preeclamptic and Normotensive Pregnant Women[] | |
| Advanced glycation end-products associate with podocytopathy in type II diabetic patients[] | |
| Non-POU Domain-Containing Octamer-Binding (NONO) Protein Stability Regulated by PIN1 is Crucial for Breast Cancer Tumorigenicity Via the MAPK/β?…[] |